Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program

被引:24
作者
Perraudin, Clemence [1 ,2 ]
Bourdin, Aline [1 ,2 ]
Spertini, Francois [3 ]
Berger, Jerome [1 ,2 ]
Bugnon, Olivier [1 ,2 ]
机构
[1] Univ Lausanne, Dept Ambulatory Care & Community Med, Community Pharm, Rue Bugnon 44, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Community Pharm, Rue Bugnon 44, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne Hosp, Div Immunol & Allergy, Rue Bugnon 44, CH-1011 Lausanne, Switzerland
关键词
Immunoglobulin; intravenous; subcutaneous; management program; interprofessional; PRIMARY ANTIBODY DEFICIENCIES; QUALITY-OF-LIFE; IGG SELF-INFUSIONS; INTRAVENOUS IMMUNOGLOBULIN; GAMMA-GLOBULIN; DIFFERENT MODALITIES; REPLACEMENT THERAPY; IMMUNODEFICIENCY; ADVANTAGES; CHILDREN;
D O I
10.1007/s10875-016-0288-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Home-based subcutaneous immunoglobulin (SCIg) therapy is an alternative to hospital-based intravenous infusions (IVIg). However, SCIg requires patient training and long-term support to ensure proper adherence, optimal efficacy and safety. We evaluated if switching patients to home-based SCIg including an interprofessional drug therapy management program (physician, community pharmacist and nurse) would be cost-effective within the Swiss healthcare system. A 3-year cost-minimization analysis was performed from a societal perspective comparing monthly IVIg in an outpatient clinic and home-based weekly SCIg including an interprofessional program. Healthcare costs (immunoglobulin, professional time, infusion pump and disposables) were derived from administrative data. Transportation and productivity loss were estimated by expert opinion. The results were expressed in Swiss francs (CHF) and converted to Euros and US dollars (1 CHF = 0.92a,not sign, 1 CHF = $1.02; www.xe.com, 12/14/2015). Under base case assumptions, SCIg was estimated to cost 35,862 CHF (33,134a,not sign; $36,595) per patient during the first year and 30,309 CHF (28,004a,not sign; $30,929) in subsequent years versus 35,370 CHF (32,679a,not sign; $36,095) per year for IVIg. The total savings from switching to SCIg with the interprofessional program were 9630 CHF (8897a,not sign; $9828) per patient over 3 years. The results were relatively sensitive to the cost per gram of IgG, the cost of equipment and the annual number of infusions. Home-based SCIg including an interprofessional therapy management program may be an efficient alternative for patients. The program provides long-term support from self-administration training to the responsible use of therapy (proper adherence, optimal efficacy and safety). Over the short term, additional costs from purchasing equipment and the drug therapy management program were offset by avoiding hospital costs.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 31 条
[1]  
[Anonymous], 2005, EFFECTIVENESS COST E
[2]  
Asia Pacific Immunoglobulins in Immunology Expert Group (APIIEG), 2009, CONS REC US IMM REPL
[3]   Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies [J].
Beaute, J. ;
Levy, P. ;
Millet, V. ;
Debre, M. ;
Dudoit, Y. ;
Le Mignot, L. ;
Tajahmady, A. ;
Thomas, C. ;
Suarez, F. ;
Pellier, I. ;
Hermine, O. ;
Aladjidi, N. ;
Mahlaoui, N. ;
Fischer, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 160 (02) :240-245
[4]  
Bourdin A, 2015, Rev Med Suisse, V11, P831
[5]  
Bourdin A, 2013, 42 EUR S CLIN PHARM, P1281
[6]  
Bourdin A, 2014, INT J CLIN PHARM, P179
[7]  
BRUTON OC, 1952, PEDIATRICS, V9, P722
[8]   The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy [J].
Chapel, HM ;
Spickett, GP ;
Ericson, D ;
Engl, W ;
Eibl, MM ;
Bjorkander, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (02) :94-100
[9]   Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies [J].
Cocito, Dario ;
Serra, Grazia ;
Paolasso, Ilaria ;
Barila, Diego A. ;
Lopiano, Leonardo ;
Cattel, Luigi .
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2012, 17 (04) :426-428
[10]  
Drummond MF, 2005, Methods for The Economic Evaluation of Health Care Programmes